Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 331

    1.

    Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases.

    Mi JQ, Wang X, Yao Y, Lu HJ, Jiang XX, Zhou JF, Wang JH, Jiao B, Shen SH, Tang JY, Gu LJ, Jiang H, Ma LY, Hao SG, Chen FY, Xiong SM, Shen ZX, Chen Z, Chen B, Chen SJ.

    Leukemia. 2012 Feb 2. doi: 10.1038/leu.2012.23. [Epub ahead of print]

    PMID:
    22297722
    [PubMed - as supplied by publisher]
    2.

    ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.

    Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP, Cymbalista F, Eichhorst B, Hallek M, Döhner H, Hillmen P, van Oers M, Gribben J, Ghia P, Montserrat E, Stilgenbauer S, Zenz T.

    Leukemia. 2012 Feb 2. doi: 10.1038/leu.2012.25. [Epub ahead of print]

    PMID:
    22297721
    [PubMed - as supplied by publisher]
    3.

    Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

    Spyridonidis A, Labopin M, Schmid C, Volin L, Yakoub-Agha I, Stadler M, Milpied N, Socie G, Browne P, Lenhoff S, Sanz MA, Aljurf M, Mohty M, Rocha V.

    Leukemia. 2012 Jan 31. doi: 10.1038/leu.2011.351. [Epub ahead of print]

    PMID:
    22290066
    [PubMed - as supplied by publisher]
    4.

    Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.

    Spijkers-Hagelstein JA, Schneider P, Hulleman E, de Boer J, Williams O, Pieters R, Stam RW.

    Leukemia. 2012 Jan 27. doi: 10.1038/leu.2011.388. [Epub ahead of print]

    PMID:
    22282267
    [PubMed - as supplied by publisher]
    5.

    A somatic EZH2 mutation in childhood acute myeloid leukemia.

    Ernst T, Pflug A, Rinke J, Ernst J, Bierbach U, Beck JF, Hochhaus A, Gruhn B.

    Leukemia. 2012 Jan 23. doi: 10.1038/leu.2012.16. [Epub ahead of print] No abstract available.

    PMID:
    22266912
    [PubMed - as supplied by publisher]
    6.

    5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.

    Castro FV, McGinn OJ, Krishnan S, Marinov G, Li J, Rutkowski AJ, Elkord E, Burt DJ, Holland M, Vaghjiani R, Gallego A, Saha V, Stern PL.

    Leukemia. 2012 Jan 23. doi: 10.1038/leu.2012.18. [Epub ahead of print]

    PMID:
    22266911
    [PubMed - as supplied by publisher]
    7.

    Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse.

    Braggio E, Kay NE, Vanwier S, Tschumper RC, Smoley S, Eckel-Passow JE, Sassoon T, Barrett M, Van Dyke DL, Byrd JC, Jelinek DF, Shanafelt TD, Fonseca R.

    Leukemia. 2012 Jan 20. doi: 10.1038/leu.2012.14. [Epub ahead of print] No abstract available.

    PMID:
    22261920
    [PubMed - as supplied by publisher]
    8.

    Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.

    Knight SJ, Yau C, Clifford R, Timbs AT, Sadighi Akha E, Dréau HM, Burns A, Ciria C, Oscier DG, Pettitt AR, Dutton S, Holmes CC, Taylor J, Cazier JB, Schuh A.

    Leukemia. 2012 Jan 19. doi: 10.1038/leu.2012.13. [Epub ahead of print]

    PMID:
    22258401
    [PubMed - as supplied by publisher]
    9.

    Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan.

    Matsumura T, Kami M, Yamaguchi T, Yuji K, Kusumi E, Taniguchi S, Takahashi S, Okada M, Sakamaki H, Azuma H, Takanashi M, Kodo H, Kai S, Inoue-Nagamura T, Kato K, Kato S.

    Leukemia. 2012 Jan 17. doi: 10.1038/leu.2012.11. [Epub ahead of print]

    PMID:
    22290068
    [PubMed - as supplied by publisher]
    10.

    Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features.

    Woyach JA, Lozanski G, Ruppert AS, Lozanski A, Blum KA, Jones JA, Flynn JM, Johnson AJ, Grever MR, Heerema NA, Byrd JC.

    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.375. [Epub ahead of print] No abstract available.

    PMID:
    22289993
    [PubMed - as supplied by publisher]
    11.

    A role for Danazol in chronic lymphocytic leukemia.

    Tung S, Spaner DE.

    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.386. [Epub ahead of print] No abstract available.

    PMID:
    22289992
    [PubMed - as supplied by publisher]
    12.

    Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.

    Porter CC, Kim J, Fosmire S, Gearheart CM, van Linden A, Baturin D, Zaberezhnyy V, Patel PR, Gao D, Tan AC, Degregori J.

    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.392. [Epub ahead of print]

    PMID:
    22289989
    [PubMed - as supplied by publisher]
    13.

    Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.

    Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, Cayuela JM, Hayette S, Reman O, Contentin N, Bordessoule D, Pautas C, Botton SD, Revel TD, Terre C, Fenaux P, Thomas X, Castaigne S, Dombret H, Preudhomme C.

    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.382. [Epub ahead of print]

    PMID:
    22289988
    [PubMed - as supplied by publisher]
    14.

    Leukemia risk models in primary myelofibrosis: an International Working Group study.

    Tefferi A, Pardanani A, Gangat N, Begna KH, Hanson CA, Van Dyke DL, Caramazza D, Vannucchi AM, Morra E, Cazzola M, Pereira A, Cervantes F, Passamonti F.

    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.374. [Epub ahead of print] No abstract available.

    PMID:
    22289985
    [PubMed - as supplied by publisher]
    15.

    Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL).

    O'Hayre M, Niederst M, Fecteau JF, Nguyen VM, Kipps TJ, Messmer D, Newton AC, Handel TM.

    Leukemia. 2012 Jan 12. doi: 10.1038/leu.2012.6. [Epub ahead of print] No abstract available.

    PMID:
    22237780
    [PubMed - as supplied by publisher]
    16.

    Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.

    Pfeifer H, Lange T, Wystub S, Wassmann B, Maier J, Binckebanck A, Giagounidis A, Stelljes M, Schmalzing M, Dührsen U, Wunderle L, Serve H, Brück P, Schmidt A, Hoelzer D, Ottmann OG.

    Leukemia. 2012 Jan 9. doi: 10.1038/leu.2012.5. [Epub ahead of print]

    PMID:
    22230800
    [PubMed - as supplied by publisher]
    17.

    Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.

    Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm S, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G.

    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.372. [Epub ahead of print]

    PMID:
    22289926
    [PubMed - as supplied by publisher]
    18.

    Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.

    Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K, Shiraga T, Goto A, Takamatsu N, Asada Y, Utsunomiya A, Okayama A, Kubuki Y, Shimoda K, Ukai Y, Kurosawa G, Morishita K.

    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.379. [Epub ahead of print]

    PMID:
    22289924
    [PubMed - as supplied by publisher]
    19.

    Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

    Daneshmanesh AH, Hojjat-Farsangi M, Khan AS, Jeddi-Tehrani M, Akhondi MM, Bayat AA, Ghods R, Mahmoudi AR, Hadavi R, Osterborg A, Shokri F, Rabbani H, Mellstedt H.

    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.362. [Epub ahead of print]

    PMID:
    22289919
    [PubMed - as supplied by publisher]
    20.

    The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.

    Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D, Bomben R, Dal Bo M, Del Principe MI, Gorgone A, Pozzato G, Gaidano G, Del Poeta G, Malavasi F, Deaglio S, Gattei V.

    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.369. [Epub ahead of print]

    PMID:
    22289918
    [PubMed - as supplied by publisher]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk